Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAS2FHIR: Transforming UIMA CAS Annotations to FHIR Bundles.

Studies in health technology and informatics·2026
Same author

Virus-specific T-cell therapy for neuroinvasive West Nile virus.

The Lancet. Neurology·2026
Same author

Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective Analysis.

Transplantation and cellular therapy·2026
Same author

Photon-counting CT for dynamic lung perfusion: validation of a low-dose protocol in a porcine lung transplantation model.

European radiology experimental·2026
Same author

Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitro.

Cancer cell international·2026
Same author

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

JAMA neurology·2026

Related Experiment Video

Updated: Jun 22, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

High-throughput minor histocompatibility antigen prediction.

David S DeLuca1, Britta Eiz-Vesper, Nektarios Ladas

  • 1Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany.

Bioinformatics (Oxford, England)
|July 3, 2009
PubMed
Summary
This summary is machine-generated.

PeptideCheck is a new bioinformatics tool to identify minor histocompatibility antigens (mHags). This system aids in discovering mHags for preventing graft-versus-host disease (GvHD) and enhancing graft-versus-leukemia (GvL) effects in transplantation.

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers
09:15

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers

Published on: July 19, 2024

Related Experiment Videos

Last Updated: Jun 22, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers
09:15

Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers

Published on: July 19, 2024

Area of Science:

  • Immunology
  • Bioinformatics
  • Computational Biology

Background:

  • Minor histocompatibility antigens (mHags) are peptides crucial in allogeneic transplantation.
  • mHags influence graft-versus-host disease (GvHD) and graft-versus-leukemia (GvL) effects.
  • Discovering mHags is vital for preventing GvHD and developing leukemia-specific therapies.

Purpose of the Study:

  • To introduce PeptideCheck, a web-based bioinformatics system for mHag discovery.
  • To augment experimental identification of mHags through computational analysis.
  • To identify potential mHags for therapeutic applications in leukemia.

Main Methods:

  • Analyzing peptide elution data to identify mHags.
  • Predicting mHags using polymorphism and protein databases.
  • Integrating single nucleotide polymorphism, protein, tissue expression, and genotypic frequency data with antigen presentation algorithms.

Main Results:

  • PeptideCheck successfully reproduced some known mHags.
  • A filtering and ranking system identified HA-1, HA-3, and HA-8 as top mHag candidates (best 0.25%).
  • A prioritized list of peptide candidates was generated to potentially induce GvL effects while minimizing GvHD.

Conclusions:

  • PeptideCheck offers a valuable bioinformatic approach for mHag discovery.
  • The system aids in identifying mHags with therapeutic potential for leukemia treatment.
  • The findings support the use of computational methods to advance transplantation immunology.